Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bi, Xin‐Gang"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-8 z 8
    Tytuł:
    Dynamic alteration and prognostic significance of tumor‐associated CD68 macrophages in muscle‐invasive bladder cancer treated with neoadjuvant chemotherapy.
    Autorzy:
    Wu, Jie
    Xie, Rui‐Yang
    Wei, Li‐Hui
    Cao, Chuan‐Zhen
    Shang, Bing‐Qing
    Guan, You‐Yan
    Shi, Hong‐Zhe
    Qu, Wang
    Li, Yun
    Liang, Jing
    Zheng, Shan
    Zhou, Ai‐Ping
    Zhou, Xiao‐Feng
    Shou, Jian‐Zhong
    Bi, Xin‐Gang
    Pokaż więcej
    Temat:
    CANCER invasiveness
    NEOADJUVANT chemotherapy
    BLADDER cancer
    REGULATORY T cells
    MACROPHAGES
    Źródło:
    Cancer Medicine; Feb2023, Vol. 12 Issue 4, p4981-4992, 12p
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Experimental and Theoretical Investigation on Rapid Evaporation of Ethanol Droplets and Kerosene Droplets During Depressurization
    Autorzy:
    Liu, Lu
    Bi, Qin-cheng
    Liu, Wei-min
    Qi, Fang-cheng
    Bi, Xin-gang
    Pokaż więcej
    Źródło:
    Microgravity Science and Technology: An International Journal for Microgravity and Space Exploration Related Research. January 2011 23(1):89-97
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Dynamic alteration and prognostic significance of tumor-associated CD68 macrophages in muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.
    Autorzy:
    Wu J; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Xie RY; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Wei LH; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
    Cao CZ; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Urology, China-Japan Friendship Hospital, Beijing, China.
    Shang BQ; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Guan YY; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Shi HZ; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Qu W; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Li Y; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
    Liang J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Zheng S; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Zhou AP; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Zhou XF; Department of Urology, China-Japan Friendship Hospital, Beijing, China.
    Shou JZ; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Bi XG; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (4), pp. 4981-4992. Date of Electronic Publication: 2022 Aug 31.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Neoadjuvant Therapy*
    Urinary Bladder Neoplasms*/pathology
    Humans ; Prognosis ; B7-H1 Antigen/metabolism ; Macrophages ; Muscles/metabolism ; Lymphocytes, Tumor-Infiltrating ; Tumor Microenvironment
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-8 z 8

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies